Publications by authors named "David C Pryde"

Claim this Profile
S
Synthesis and structure-activity evaluation of a series of novel tricyclic STING activators.
Sourav Basu, Sandip Middya, Ritesh Shrivastava, David C Pryde, Rajib Ghosh

Eur J Med Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of potent small molecule cyclic urea activators of STING.
Sourav Basu, Sandip Middya, Monali Banerjee, Rajib Ghosh, David C Pryde

Eur J Med Chem· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of potent small molecule activators of human STING.
David C Pryde, Sandip Middya, Monali Banerjee, Ritesh Shrivastava, Sourav Basu

Eur J Med Chem· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G10 is a direct activator of human STING.
Monali Banerjee, Sandip Middya, Ritesh Shrivastava, Sourav Basu, Rajib Ghosh, David C Pryde

PLoS One· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valproic acid interactions with the NavMs voltage-gated sodium channel.
Geancarlo Zanatta, Altin Sula, Andrew J Miles, Leo C T Ng, Rubben Torella, David C Pryde

Proc Natl Acad Sci U S A· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Identification of a Novel, Functionally Subtype Selective GABA Positive Allosteric Modulator (PF-06372865).
Robert M Owen, David Blakemore, Lishuang Cao, Neil Flanagan, Rebecca Fish, David C Pryde

J Med Chem· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pharmacological master key mechanism that unlocks the selectivity filter gate in K channels.
Marcus Schewe, Han Sun, Ümit Mert, Alexandra Mackenzie, Ashley C W Pike, David C Pryde

Science· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRPA1 ankyrin repeat six interacts with a small molecule inhibitor chemotype.
Wei Chou Tseng, David C Pryde, Katrina E Yoger, Karen M Padilla, Brett M Antonio

Proc Natl Acad Sci U S A· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Intracellular Allosteric Modulator Binding Pocket in SK2 Ion Channels Is Shared by Multiple Chemotypes.
Lily T-Y Cho, Aristos J Alexandrou, Rubben Torella, John Knafels, Jake Hobbs, David C Pryde

Structure· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Series of Indazole TRPA1 Antagonists.
David C Pryde, Brian E Marron, Christopher W West, Steven Reister, George Amato

ACS Med Chem Lett· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1" [Bioorg. Med. Chem. Lett. 26 (2016) 4919-4924].
Aymeric Monteillier, Alexandre Loucif, Kiyoyuki Omoto, Edward B Stevens, Sergio Lainez, David C Pryde

Bioorg Med Chem Lett· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-selective Suzuki-Miyaura coupling of heteroaryl halides - understanding the trends for pharmaceutically important classes.
Joshua Almond-Thynne, David C Blakemore, David C Pryde, Alan C Spivey

Chem Sci· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Differential Efficacy and Affinity of GABA (α1/α2) Selective Modulators.
Qurrat U Ain, Robert M Owen, Kiyoyuki Omoto, Rubben Torella, Krishna C Bulusu, David C Pryde

Mol Pharm· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K18.1.
Aymeric Monteillier, Alexandre Loucif, Kiyoyuki Omoto, Edward B Stevens, Sergio Lainez, David C Pryde

Bioorg Med Chem Lett· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis for inhibition of a voltage-gated Ca channel by Ca antagonist drugs.
Lin Tang, Tamer M Gamal El-Din, Teresa M Swanson, David C Pryde, Todd Scheuer

Nature· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
11th German Conference on Chemoinformatics (GCC 2015) : Fulda, Germany. 8-10 November 2015.
Uli Fechner, Chris de Graaf, Andrew E Torda, Stefan Güssregen, Andreas Evers, David C Pryde

J Cheminform· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Selective TRPM8 Antagonist with Clinical Efficacy in Cold-Related Pain.
Mark D Andrews, Kerry Af Forselles, Kevin Beaumont, Sébastien R G Galan, Paul A Glossop, David C Pryde

ACS Med Chem Lett· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of potent nonstructural protein 5A (NS5A) inhibitors with a unique resistance profile-Part 1.
Thien Duc Tran, Florian Wakenhut, Chris Pickford, Stephen Shaw, Mike Westby, David C Pryde

ChemMedChem· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of potent nonstructural protein 5A (NS5A) inhibitors with a unique resistance profile-Part 2.
Florian Wakenhut, Thien Duc Tran, Chris Pickford, Stephen Shaw, Mike Westby, David C Pryde

ChemMedChem· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-π interaction.
Timothy P C Rooney, Panagis Filippakopoulos, Oleg Fedorov, Sarah Picaud, Wilian A Cortopassi, David C Pryde

Angew Chem Int Ed Engl· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prokaryotic NavMs channel as a structural and functional model for eukaryotic sodium channel antagonism.
Claire Bagnéris, Paul G DeCaen, Claire E Naylor, David C Pryde, Irene Nobeli

Proc Natl Acad Sci U S A· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of acyclic phosphonic acid nucleoside derivatives.
Philip Wainwright, Adrian Maddaford, Xiurong Zhang, Helen Billington, David Leese, David C Pryde

Nucleosides Nucleotides Nucleic Acids· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in mice.
David C Pryde, Lyn H Jones, David P Gervais, David R Stead, David C Blakemore

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing immunogenicity of a 3'aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates.
Michael J McCluskie, David C Pryde, David P Gervais, David R Stead, Ningli Zhang

Int Immunopharmacol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-benzimidazole containing inhibitors of respiratory syncytial virus.
David C Pryde, Thien-Duc Tran, Iain Gardner, Helen Bright, Paul Stupple

Bioorg Med Chem Lett· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis